VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TIL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TILInstil Bio, Inc.
$7.75$53M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTILQuarterly Financials

Instil Bio, Inc. (TIL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Instil Bio, Inc. (TIL) quarterly income statement — complete revenue, gross profit & net income history

TIL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold12K012K00741K00993K1.04M0000000000
COGS % of Revenue--------------------
Gross Profit-12K0-12K00-741K00-993K-1.04M0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%--100%28.47%--------------
Operating Expenses6.01M9.56M15.01M23.44M30.56M10.73M23.63M14.13M18.69M11.82M66.72M20.99M58.45M56.8M56.65M58.72M54.29M53.75M43.02M35.38M
OpEx % of Revenue--------------------
Selling, General & Admin5.35M6.06M5.89M6.16M9.11M9.63M10.71M10.71M11.43M9.84M11.94M11.52M13.22M12.91M16.99M17.22M15.11M14.18M13.96M14.2M
SG&A % of Revenue--------------------
Research & Development669K3.5M9.13M6.74M5.37M1.1M562K2.92M7.26M1.98M8.49M8.46M20.67M20.72M39.66M41.5M39.17M42.58M29.06M21.19M
R&D % of Revenue--------------------
Other Operating Expenses-12K001000K1000K01000K508K001000K1000K1000K1000K000-1000K00
Operating Income-6.02M-9.56M-15.02M-23.44M-30.56M-11.47M-23.63M-14.13M-19.68M-12.86M-66.72M-20.99M-58.45M-56.8M-56.65M-58.72M-54.29M-53.75M-43.02M-35.38M
Operating Margin %--------------------
Operating Income Growth %80.31%16.69%36.43%-65.83%-55.29%10.76%64.58%32.65%66.33%77.37%-17.77%64.26%-7.66%-5.67%-31.67%-65.98%-131.96%-207.56%--
EBITDA-6.01M-9.54M-14.77M-23.43M-30.06M-10.73M-22.73M-13.16M-18.69M-11.82M-65.76M-20M-56.67M-54.7M-54.71M-57.67M-53.39M-52.86M-42.26M-34.73M
EBITDA Margin %--------------------
EBITDA Growth %80.02%11.05%35.03%-78.02%-60.88%9.21%65.44%34.19%67.02%78.39%-20.2%65.33%-6.15%-3.48%-29.46%-66.09%-132.48%-205.03%--
D&A (Non-Cash Add-back)12K12K255K12K498K741K901K975K993K1.04M953K991K1.78M2.1M1.94M1.05M899K893K764K656K
EBIT-6.02M-7.42M-12.01M-19.81M-27.31M-9.3M-21.01M-12.92M-22.57M-10.95M-65.43M-18.07M-56.68M-53.7M-55.79M-59.27M-54.6M-53.46M-43.66M-35.47M
Net Interest Income-874K-30K-689K-538K77K-1.24M-353K-80K81K215K310K1.7M1.44M1.05M469K155K97K-538K22K15K
Interest Income678K746K893K1.04M1.18M1.35M1.65M1.92M2.06M2.19M2.31M2.29M2.07M1.8M1.28M486K97K022K15K
Interest Expense1.55M776K1.58M1.58M1.1M2.59M2.01M2M1.98M1.98M2M590K636K745K807K331K0538K00
Other Income/Expense1.81M1.37M1.44M2.05M2.36M-423K610K-782K-4.62M-70K-716K2.33M1.38M2.35M54K-877K-319K-538K-639K-89K
Pretax Income-4.2M-8.19M-13.59M-21.39M-28.2M-11.89M-23.02M-14.92M-24.3M-12.93M-67.43M-18.66M-57.07M-54.45M-56.59M-59.6M-54.6M-54.29M-43.66M-35.47M
Pretax Margin %--------------------
Income Tax0000000000000-605K-371K-609K-488K1.06M-658K-159K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%1.11%0.66%1.02%0.89%-1.95%1.51%0.45%
Net Income-4.2M-8.19M-13.59M-21.39M-28.2M-11.89M-23.02M-14.92M-24.3M-12.93M-67.43M-18.66M-57.07M-53.84M-56.22M-58.99M-54.12M-55.35M-43.01M-35.31M
Net Margin %--------------------
Net Income Growth %85.09%31.14%40.98%-43.42%-16.04%7.97%65.86%20.07%57.42%76%-19.93%68.37%-5.45%2.72%-30.74%-67.06%-133.99%-222.08%--
Net Income (Continuing)-4.2M-8.19M-13.59M-21.39M-28.2M-11.89M-23.02M-14.92M-24.3M-12.93M-67.43M-18.66M-57.07M-53.84M-56.22M-58.99M-54.12M-55.35M-43.01M-35.31M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.62-1.21-2.01-3.24-4.32-1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27
EPS Growth %85.65%33.52%43.22%-41.48%-15.51%8.54%65.86%20.21%56.81%76%-2311.63%-523.91%-1961.9%-1827.91%-30.3%-70.37%36.36%12.24%--
EPS (Basic)-0.62-1.21-2.01-3.24-4.32-1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27
Diluted Shares Outstanding6.78M6.78M6.76M6.6M6.53M6.53M6.51M6.5M6.5M6.5M6.5M6.5M6.5M6.49M129.68M129.37M129.12M128.95M128.79M128.74M
Basic Shares Outstanding6.78M6.78M6.76M6.6M6.53M6.53M6.51M6.5M6.5M6.5M6.5M6.5M6.5M6.49M129.68M129.37M129.12M128.95M128.79M128.74M
Dividend Payout Ratio--------------------